Randomized phase III study of maintenance selinexor versus placebo in endometrial cancer (ENGOT-EN5/GOG-3055/SIENDO): Impact of subgroup analysis and molecular classification Meeting Abstract
| Authors: | Makker, V.; Perez-Fidalgo, J. A.; Bergamini, A.; Spitz, D. L.; Van Gorp, T.; Sehouli, J.; Klat, J.; Perri, T.; Oza, A. M.; Hogdall, E. V. S.; Konner, J. A.; Guerra, E. M.; Raspagliesi, F.; Henry, S.; Monk, B. J.; Garcia, J. M.; Slomovitz, B. M.; Shacham, S.; Mirza, M. R.; Vergote, I. |
| Abstract Title: | Randomized phase III study of maintenance selinexor versus placebo in endometrial cancer (ENGOT-EN5/GOG-3055/SIENDO): Impact of subgroup analysis and molecular classification |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301564 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.5511 |
| Notes: | Meeting Abstract: 5511 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
